graft-versus-host disease

(redirected from Graft versus host)
Also found in: Medical, Acronyms.

graft-ver·sus-host disease

(grăft′vûr′səs-hōst′, -səz-)
n.
A condition in which cells from the transplanted tissue of a donor initiate an immunologic attack on the cells and tissue of the recipient.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

graft′-ver`sus-host′ disease`


n.
a reaction in which the cells of transplanted tissue immunologically attack the cells of the host.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
Teixeira, "The role of chemokines in mediating graft versus host disease: opportunities for novel Therapeutics," Frontiers in Pharmacology, vol.
The report provides comprehensive information on the therapeutics under development for Graft Versus Host Disease (GVHD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
This report provides comprehensive information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
So based on the history and clinical examination we considered a provisional diagnosis of Transfusion associated Chronic Graft Versus Host Disease considering Lupus erythematosis as a differential diagnosis.
"Importantly, in 2014 we plan to have active products in Phase 3 clinical trials in all four core major therapeutic areas of focus: cardiovascular medicine (congestive heart failure) inflammatory/ immune diseases (Crohn's disease), orthopedics (spinal fusion and interverbral disc repair) and oncology (acute Graft versus Host Disease and cord blood expansion in bone marrow transplantation."
Chronic graft versus host disease; interdisciplinary management.
They launch attacks which can prove fatal in the worst cases, a condition called graft versus host disease.
Secondly, Adrian has developed a post-transplant complication called chronic graft versus host disease.